ARAN - Access to Research at NUI Galway

A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats.

ARAN - Access to Research at NUI Galway

Show simple item record

dc.contributor.author Ford, Gemma K.
dc.contributor.author Kieran, Siobhan
dc.contributor.author Dolan, Kenneth
dc.contributor.author Harhen, Brendan
dc.contributor.author Finn, David P.
dc.date.accessioned 2012-01-24T10:21:39Z
dc.date.available 2012-01-24T10:21:39Z
dc.date.issued 2011-08
dc.identifier.citation Ford GK, Kieran S, Dolan K, Harhen B, Finn DP (2011). A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats. Pain, 152(11):2495-504 en_US
dc.identifier.uri http://hdl.handle.net/10379/2525
dc.description.abstract The endogenous cannabinoid (endocannabinoid) system plays an important role in fear-conditioned analgesia (FCA) and expression and extinction of conditioned fear. The hippocampus has an established role in both pain and conditioned fear and is a substrate for endocannabinoid activity. This study aimed to investigate the role of the endocannabinoid system in the ventral hippocampus (vHip) in FCA and in fear responding in the presence of nociceptive tone. Fear-conditioned rats displayed significantly increased freezing and 22-kHz ultrasonic vocalisation and a reduction in formalin-evoked nociceptive behaviour (ie, FCA) upon re-exposure to a context previously paired with footshock. Tissue levels of the endocannabinoids, anandamide, and 2-arachidonoylglycerol, as well as the fatty acid amide, palmitoylethanolamide, were significantly higher in the vHip of fear-conditioned rats compared with non-fear-conditioned controls. URB597 (inhibitor of fatty acid amide hydrolase [FAAH]), administered bilaterally into the vHip, significantly enhanced FCA during the entire trial and increased fear responding in formalin-treated rats early in the trial. The URB597-induced enhancement of FCA was blocked by intra-vHip administration of the cannabinoid(1) (CB(1)) receptor antagonist/inverse agonist rimonabant. Intra-vHip rimonabant alone had no effect on the expression of FCA, and URB597 did not significantly alter formalin-evoked nociceptive behaviour in non-fear-conditioned rats. These data suggest an important role for the endocannabinoid system in the vHip in FCA, whereby levels of 2-arachidonoylglycerol and the FAAH substrates palmitoylethanolamide and anandamide are increased in rats expressing FCA, and pharmacological inhibition of FAAH in the vHip enhances this form of endogenous analgesia via a CB(1) receptor-dependent mechanism. en_US
dc.format application/pdf en_US
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.subject Pain en_US
dc.subject Fear en_US
dc.subject Ventral hippocampus en_US
dc.subject Cannabinoid type 1 (CB1) receptor en_US
dc.subject Fatty acid amide hydrolase (FAAH) en_US
dc.subject URB597 en_US
dc.subject Endocannabinoids en_US
dc.subject N-Acylethanolamines en_US
dc.title A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats. en_US
dc.type Article en_US
dc.description.peer-reviewed peer-reviewed en_US
dc.contributor.funder SFI en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record